Latest News Sore throat. Sneezing. Coughing. Is it allergies...

July 27, 2022

The latest COVID-19 subvariants have pushed hospitalizations and cases in Greater Cincinnati high enough that the Centers for Disease Control and Prevention last week recommended indoor masking in eight local counties. Many people are experiencing symptoms including scratchy sore throat, runny nose, a cough and a headache, raising the question of whether the symptoms are from COVID or allergies. asked some local experts to weigh in, including Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.

WXVU: New variants of COVID are rising fast. What does that mean...

July 12, 2022

New variants of COVID-19 continue to emerge — and some research suggests they're more contagious than ever. Troublingly, those variants seem to be more resistant to vaccines than past versions of the virus — and they're becoming the predominant strains of COVID in the United States. WVXU interviewed Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine to learn more about the BA.4 and BA.5 COVID variants.

UC to develop new cancer treatments

June 7, 2022

A chemical engineering professor at the University of Cincinnati will work with a South Korean pharmaceutical company to develop new cancer treatments using the technology found in some COVID-19 vaccines UC College of Engineering and Applied Science professor Joo-Youp Lee will work with Yuhan Corp. and Ewha Womans University in South Korea to improve the delivery of treatments that use messenger RNA and lipid nanoparticles. This technology also is being used to treat infectious diseases and genetic disorders.

Spectrum News: Doctors explain high COVID-19 death rate despite...

May 19, 2022

With the United States recently hitting one million COVID-19 deaths, many are wondering why there have been so many deaths despite having a higher than average vaccination rate. Medical professionals explained the current climate of COVID-19 in the hospitals and area communities. One of the experts interviewed for a story posted by Spectrum News was Carl Fichtenbaum, MD, professor in the Division of Infectious Diseases at the UC College of Medicine.

Medscape: Analysis boosts Fluvoxamine for COVID, but what's the...

April 14, 2022

A report published recently in JAMA Open Network finds there's a strong likelihood that the antidepressant fluvoxamine (Luvox) may moderately lower rates of hospitalization due to COVID-19 in unvaccinated patients. However, outside experts cited by Medscape differ over whether the evidence from just three studies is strong enough to warrant adding the drug to the COVID-19 armamentarium. One of those experts sources is Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.

HuffPost: Is there any way to reduce your risk of long COVID if...

March 21, 2022

Since the start of the pandemic two years ago, it’s become more and more difficult to avoid COVID-19, especially as the virus has mutated to become more contagious. We know that high-quality masks help and vaccination drastically reduces our odds of contracting the coronavirus and developing serious illness. But given the nature of extremely contagious respiratory viruses such as SARS-CoV-2, infectious disease specialists say that most of us will, at some point, get infected. And as the reality of living with endemic COVID sets in, many of us have grown increasingly concerned about getting long COVID if and when that infection occurs. In a story on long COVID posted by HuffPost, Richard Becker, MD, professor and director, UC Heart, Lung and Vascular Institute and UC Division of Cardiovascular Health and Disease at the UC College of Medicine was one of the experts cited.

Load More
Debug Query for this